Rankings
▼
Calendar
LGVN FY 2018 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$18M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$680,649
31.9% margin
Operating Income
-$6M
-298.0% margin
Net Income
-$6M
-296.8% margin
EPS (Diluted)
$-3.98
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$423,866
Balance Sheet
Total Assets
$11M
Total Liabilities
$4M
Stockholders' Equity
$7M
Cash & Equivalents
$4M
← FY 2019
All Quarters